vimarsana.com

Page 46 - தலைமை சட்டப்பூர்வமானது அதிகாரி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Altus Power Announces Appointment of Sophia Lee As Chief Legal Officer

Altus Power Announces Appointment of Sophia Lee As Chief Legal Officer Ms. Lee brings experience in technology sector, regulatory matters and complex transactions News provided by Share this article Share this article GREENWICH, Conn., May 14, 2021  Altus Power America, Inc. ( Altus or the Company ) today announced the appointment of Sophia Lee as Chief Legal Officer. In this role, Ms. Lee will oversee all legal and compliance matters for the Company. Ms. Lee brings twenty-five years of legal experience to the position, having guided strategic business initiatives for public and high-growth private companies while also managing corporate governance, mergers and acquisitions, complex commercial transactions, intellectual property, litigation, and regulatory matters.

A Chief Legal Officer s Guide to AI-Based eDiscovery and Analytics | ZyLAB

Introduction As a Chief Legal Officer (CLO), you wear a number of different hats. You’re responsible for managing your organization’s risk profile in both legal and regulatory compliance issues, overseeing current matters, and supervising the legal department and on top of that, you need to dedicate a substantial portion of your time to strategic guidance for the rest of the business. If you feel like you’re stretched too thin, you’re not alone. But there’s a willing assistant ready to help you out whenever you ask. This assistant doesn’t mind drudgery and will never complain about doing the same task over and over (and over). Nor does this helper shy away from massive reams of data in fact, this assistant needs that data to do its job. We’re talking, of course, about artificial intelligence (AI), which can streamline work processes, knock out repetitive tasks with ease, and sift through piles of data in short order, highlighting the potentially interesting portions f

Nominate Now: D CEO s Corporate Counsel Awards

D CEO’s Corporate Counsel Awards The annual recognition program honors top in-house attorneys in Dallas-Fort Worth, from outstanding up-and-comer to outstanding general counsel. By Kelsey Vanderschoot Published in Business & Economy May 12, 2021 5:42 pm For 12 years, D CEO magazine has honored outstanding in-house attorneys across the North Texas region. We are gearing up to do so again but we need your help. Nominations are now open, with a deadline of June 23. The nomination form will take just a few minutes to complete. We will then send the nominee a quick Q&A to collect additional information. (Nominator names will not be disclosed.)

Quebecor Inc reports consolidated results for first quarter 2021

Share this article Share this article MONTRÉAL, May 13, 2021 /PRNewswire/ - Quebecor Inc. ( Quebecor or the Corporation ) today reported its consolidated financial results for the first quarter of 2021. Quebecor consolidates the financial results of its wholly owned Quebecor Media Inc. ( Quebecor Media ) subsidiary. First quarter 2021 highlights Adjusted EBITDA: Adjusted income from continuing operating activities: 2 $129.9 million ($0.52 per basic share), an increase of $18.4 million ($0.08 per basic share) or 16.5%. Net income attributable to shareholders: $121.3 million ($0.49 per basic share), a decrease of $10.3 million ($0.03 per basic share). Cash flows from operations: 3 $307.6 million, up $12.6 million (4.3%). The Telecommunications segment grew its revenues by $39.3 million (4.5%) and its adjusted EBITDA by $15.4 million (3.5%) in the first quarter of 2021.

Cogent Biosciences Provides Corporate Updates and Reports First Quarter 2021 Financial Results

Cogent Biosciences Provides Corporate Updates and Reports First Quarter 2021 Financial Results IND cleared for Phase 2 study of CGT9486, a selective mutant KIT inhibitor, in Advanced Systemic Mastocytosis patients John Robinson, PhD appointed as Chief Scientific Officer to lead newly created Cogent Research team Evan Kearns, JD joined Cogent as Chief Legal Officer Ended Q1 2021 with $230.7 million in cash, sufficient to fund operations into 2024 News provided by Share this article Share this article CAMBRIDGE, Mass. and BOULDER, Colo., May 12, 2021 /PRNewswire/  Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced financial results for the first quarter ended March 31, 2021 and provided several corporate updates.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.